000 01579 a2200457 4500
005 20250514225003.0
264 0 _c20051007
008 200510s 0 0 eng d
022 _a0167-6997
024 7 _a10.1007/s10637-005-6733-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMéndez, M
245 0 0 _aWeekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer.
_h[electronic resource]
260 _bInvestigational new drugs
_cJun 2005
300 _a243-51 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aCamptothecin
_xadministration & dosage
650 0 4 _aColorectal Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIrinotecan
650 0 4 _aLeucovorin
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aTegafur
_xadministration & dosage
650 0 4 _aUracil
_xadministration & dosage
700 1 _aAlfonso, P G
700 1 _aPujol, E
700 1 _aGonzález, E
700 1 _aCastañon, C
700 1 _aCerezuela, P
700 1 _aLópez-Mateos, Y
700 1 _aCruz, J J
773 0 _tInvestigational new drugs
_gvol. 23
_gno. 3
_gp. 243-51
856 4 0 _uhttps://doi.org/10.1007/s10637-005-6733-0
_zAvailable from publisher's website
999 _c15534543
_d15534543